Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v1-EN
Language English English
Date Updated 2022-09-23 2022-08-18
Drug Identification Number 00389218 00389218
Brand name NOVO-GESIC NOVO-GESIC
Common or Proper name ACETAMINOPHEN ACETAMINOPHEN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ACETAMINOPHEN ACETAMINOPHEN
Strength(s) 325MG 325MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N02BE N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-08-18 2022-08-18
Estimated end date 2022-09-20 2022-11-10
Actual end date 2022-09-22
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments